NCT00343226View on ClinicalTrials.gov

"An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in de Novo Liver Transplantation."

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 30, 2005

Conditions
Liver Transplantation
Interventions
DRUG

Basiliximab

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00343226 - "An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in de Novo Liver Transplantation." | Biotech Hunter | Biotech Hunter